SAN FRANCISCO, Feb. 28, 2025 /PRNewswire/ — On February 25, 2025, the share price of Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plummeted 21% after […]
Tag: Hagens Berman Sobol Shapiro LLP
Crocs, Inc. (CROX) Faces Securities Class Action over HEYDUDE Pipeline
CROX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Feb. 28, 2025 /PRNewswire/ — Investors in Crocs, Inc. (NASDAQ: CROX) suffered yet another loss on Oct. 29, 2024 after the company prepared investors […]
Semtech Corporation (SMTC) Faces Class Action Suit Over Alleged CopperEdge™ Misrepresentations
SAN FRANCISCO, Feb. 25, 2025 /PRNewswire/ — A class action lawsuit has been filed against Semtech Corporation (NASDAQ: SMTC), a prominent high-performance, semiconductor, Internet of Things systems and cloud connectivity service provider, alleging that the […]
TransMedics Group (TMDX) Faces Class-Action Suit Over Alleged Fraud and Safety Lapses- Hagens Berman
SAN FRANCISCO, Feb. 21, 2025 /PRNewswire/ — A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant therapy, alleging that the company and certain executives […]
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman
SAN FRANCISCO, Jan. 3, 2025 /PRNewswire/ — Shares of BioAge (NASDAQ: BIOA) have plummeted since the company’s December 6 announcement of the discontinuation of a Phase 2 trial for its weight-loss drug azelaprag due to safety […]
